ArriVent BioPharma (AVBP) Shares Issued (2023 - 2026)

ArriVent BioPharma (AVBP) has 4 years of Shares Issued data on file, last reported at $2.0 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Issued fell 51.05% year-over-year to $2.0 million; the trailing twelve-month figure through Mar 2026 stood at $2.0 million (down 51.05% YoY), and the FY2025 full-year result was $4.3 million, up 71.02% from the prior year.
• Shares Issued eased to $2.0 million in Q1 2026, from $4.3 million in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $4.4 million in Q3 2025 to a low of $564452.0 in Q1 2024.
• A 4-year average of $2.5 million and a median of $2.3 million in 2024 frame the typical range for Shares Issued.
• Across the five-year window, Shares Issued soared 619.16% in 2025 and tumbled 51.05% in 2026, its largest moves.
• Tracing AVBP's Shares Issued over 4 years: stood at $1.7 million in 2023, then surged by 50.38% to $2.5 million in 2024, then jumped by 71.02% to $4.3 million in 2025, then plunged by 54.1% to $2.0 million in 2026.
• Business Quant data shows AVBP's Shares Issued at $2.0 million in Q1 2026, $4.3 million in Q4 2025, and $4.4 million in Q3 2025.